Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

NCT00700765 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00700765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2008
Enrollment
1,531 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2